Skip to content

Author

Xiang-Peng Dai

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Cancer degronopathies and protein-fate biomarkers in drug resistance and cancer progression: signalling mechanisms, measurement and translational limits

Drug resistance remains a major barrier to durable targeted therapy, and cancer progression often reflects rewiring of signalling pathways that control protein stability. Dysregulation of the ubiquitin–proteasome system, including failure of degron-dependent substrate recognition, can stabilise oncogenic proteins, acce...

Jia-Xin Li, Shu-Han Liu, Lu Fu et al. · 0 citations
Review Open access Aug 2026

OTULIN: a master regulator of linear ubiquitin homeostasis in immune signaling, inflammation, and disease

A comprehensive overview of OTULIN’s structural features, regulatory mechanisms, biological functions, roles in pathogenesis, and potential therapeutic intervention strategies are provided to inform future mechanistic studies and facilitate translational advances in targeted therapies.

Ziyu Zhang, Jiahang Lyu, Yu-Jie Bai et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.